The Intertransverse Process Block for Minor Breast Cancer Surgery – Single or Multiple Injection? A randomised, procedure related, blinded clinical trial.

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501312-34-00

Acronym

ZUH-ITP-MBCS

Enrollment

Registered

2022-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Brief summary

The primary outcome of this procedure related study is the number of anaesthetised thoracic dermatomes

Detailed description

“Sensory mapping”: the extent of cutaneous spread of the sensory block (area in cm2), To evaluate thermography in a clinical setup (the temperature differences between non-blockade side and blockade side), To evaluate changes in non-invasive blood pressure, To evaluate block application numeric rating scale scores

Interventions

DRUGRopivacain Fresenius Kabi 7

DRUG5 mg/ml

DRUGinjektionsvätska

DRUGlösning

DRUGLIDOCAINE

DRUGALFENTANIL

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
The primary outcome of this procedure related study is the number of anaesthetised thoracic dermatomes	—

Secondary

Measure	Time frame
“Sensory mapping”: the extent of cutaneous spread of the sensory block (area in cm2), To evaluate thermography in a clinical setup (the temperature differences between non-blockade side and blockade side), To evaluate changes in non-invasive blood pressure, To evaluate block application numeric rating scale scores	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026